# Sister haplotypes and recombination disequilibrium: a new approach to identify associations of haplotypes with complex diseases

**Authors:** Shun-Yao Liao, Yuan-De Tan

PMC · DOI: 10.3389/fgene.2023.1295327 · Frontiers in Genetics · 2024-01-16

## TL;DR

This paper introduces a new method using sister haplotypes and recombination disequilibrium to better identify genetic associations with complex diseases.

## Contribution

A novel approach using sister haplotypes and recombination disequilibrium to detect true haplotype-disease associations.

## Key findings

- Sister haplotypes containing ApoE3/4 are associated with Alzheimer's disease risk under no recombination disequilibrium.
- Haplotypes in IL-13 are not linked to breast cancer risk when recombination disequilibrium is absent.
- Haplotypes in IL-17A do not associate with coronary artery disease risk without recombination disequilibrium.

## Abstract

Haplotype-based association analysis has several advantages over single-SNP association analysis. However, to date all haplotype-disease associations have not excluded recombination interference among multiple loci and hence some results might be confounded by recombination interference. Association of sister haplotypes with a complex disease, based on recombination disequilibrium (RD) was presented. Sister haplotypes can be determined by translating notation of DNA base haplotypes to notation of genetic genotypes. Sister haplotypes provide haplotype pairs available for haplotype-disease association analysis. After performing RD tests in control and case cohorts, a two-by-two contingency table can be constructed using sister haplotype pair and case-control pair. With this standard two-by-two table, one can perform classical Chi-square test to find statistical haplotype-disease association. Applying this method to a haplotype dataset of Alzheimer disease (AD), association of sister haplotypes containing ApoE3/4 with risk for AD was identified under no RD. Haplotypes within gene IL-13 were not associated with risk for breast cancer in the case of no RD and no association of haplotypes in gene IL-17A with risk for coronary artery disease were detected without RD. The previously reported associations of haplotypes within these genes with risk for these diseases might be due to strong RD and/or inappropriate haplotype pairs.

## Linked entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348], IL13 (interleukin 13) [NCBI Gene 3596], IL17A (interleukin 17A) [NCBI Gene 3605]
- **Diseases:** Alzheimer disease (MONDO:0004975), breast cancer (MONDO:0004989), coronary artery disease (MONDO:0005010)

## Full-text entities

- **Genes:** IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}
- **Diseases:** anxiety (MESH:D001007), ADHD (MESH:D001289), CCA (MESH:C536211), RD (MESH:C535296), AD (MESH:D000544), bipolar disorder (MESH:D001714), Breast cancer (MESH:D001943), mental illness (MESH:D001523), OCD (MESH:D009771), CAD (MESH:D003324), schizophrenia (MESH:D012559), eating disorders (MESH:D001068), panic disorder (MESH:D016584)
- **Chemicals:** TAGA (MESH:C013283)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** rs2239393, C at site 1, G at site 3, -2044 G/A, rs3819024, C at site 2, rs46462316, rs8193036, rs1544325, rs8193037, rs174674, rs4680, -1512 A/C, rs2275913, 2044 G/A, rs7290221, -1055 C/T

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10825010/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC10825010/full.md

---
Source: https://tomesphere.com/paper/PMC10825010